Education
About Us
Working with TipRanks
Follow Us
Spruce Biosciences (SPRB)
NASDAQ:SPRB
See the Price Targets and Ratings of:
SPRB Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
―
Hold
―
Reiterated
12/16/24
Hold Rating for Spruce Biosciences Amid Clinical Setbacks and Strategic Uncertainties
JMP Securities
―
Hold
―
Downgraded
12/11/24
JMP Securities downgrades Spruce Biosciences (SPRB) to a Hold
Oppenheimer
―
Hold
―
Downgraded
12/11/24
Spruce Biosciences Downgraded to Hold Amid Unmet Clinical Trial Endpoints and Strategic Reevaluation
Leerink Partners
$2→$1
Hold
244.83%
Upside
Reiterated
12/10/24
Spruce Biosciences Faces Setbacks with Tildacerfont Program, Hold Rating Maintained
RBC Capital
$2→$1.5
Hold
417.24%
Upside
Reiterated
12/10/24
RBC Capital Remains a Hold on Spruce Biosciences (SPRB)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
―
Hold
―
Reiterated
12/16/24
Hold Rating for Spruce Biosciences Amid Clinical Setbacks and Strategic Uncertainties
JMP Securities
―
Hold
―
Downgraded
12/11/24
JMP Securities downgrades Spruce Biosciences (SPRB) to a Hold
Oppenheimer
―
Hold
―
Downgraded
12/11/24
Spruce Biosciences Downgraded to Hold Amid Unmet Clinical Trial Endpoints and Strategic Reevaluation
Leerink Partners
$2→$1
Hold
244.83%
Upside
Reiterated
12/10/24
Spruce Biosciences Faces Setbacks with Tildacerfont Program, Hold Rating Maintained
RBC Capital
$2→$1.5
Hold
417.24%
Upside
Reiterated
12/10/24
RBC Capital Remains a Hold on Spruce Biosciences (SPRB)
SPRB Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Nov 24
Dec 24
Strong Buy
4
4
3
2
3
Buy
0
0
0
0
0
Hold
5
4
3
5
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
8
6
7
11
Each month's total comprises the sum of three months' worth of ratings.
SPRB Stock Forecast FAQ
What is SPRB’s average 12-month price target, according to analysts?
Based on analyst ratings, Spruce Biosciences’s 12-month average price target is $1.25.
What is SPRB’s upside potential, based on the analysts’ average price target?
Spruce Biosciences has 331.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SPRB a Buy, Sell or Hold?
Spruce Biosciences has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Spruce Biosciences’s price target?
The average price target for Spruce Biosciences is $1.25. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1.50 ,the lowest forecast is $1.00. The average price target represents 331.03% Increase from the current price of $0.29.
The highest analyst price target is $1.50 ,the lowest forecast is $1.00. The average price target represents 331.03% Increase from the current price of $0.29.
What do analysts say about Spruce Biosciences?
Spruce Biosciences’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of SPRB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.